118 related articles for article (PubMed ID: 2879624)
1. Identification and partial characterization of a Mr 40,000 nucleolar antigen associated with cell proliferation.
Chatterjee A; Freeman JW; Busch H
Cancer Res; 1987 Feb; 47(4):1123-9. PubMed ID: 2879624
[TBL] [Abstract][Full Text] [Related]
2. Identification and partial characterization of a Mr 105,000 nucleolar antigen associated with cell proliferation.
Chatterjee A; Freeman JW; Busch H
Cancer Res; 1987 Dec; 47(23):6329-34. PubMed ID: 3479243
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase.
Freeman JW; Busch RK; Gyorkey F; Gyorkey P; Ross BE; Busch H
Cancer Res; 1988 Mar; 48(5):1244-51. PubMed ID: 3422591
[TBL] [Abstract][Full Text] [Related]
4. Identification and partial characterization of a nucleolar antigen with a molecular weight of 145,000 found in a broad range of human cancers.
Freeman JW; McRorie DK; Busch RK; Gyorkey F; Gyorkey P; Ross BE; Spohn WH; Busch H
Cancer Res; 1986 Jul; 46(7):3593-8. PubMed ID: 3518918
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of complementary DNA to proliferating cell nucleolar antigen P40.
Reddy AB; Chatterjee A; Rothblum LI; Black A; Busch H
Cancer Res; 1989 Apr; 49(7):1763-7. PubMed ID: 2466560
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody identifies a 215 000-dalton nuclear envelope protein restricted to certain cell types.
Brown G; Turner BM; Morris CJ; Bahman AM; Fisher AG; Whitfield WG; Davies S; Barthakur R; Johnson GD
Eur J Cell Biol; 1985 Nov; 39(1):86-96. PubMed ID: 2417847
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a nuclear antigen (Mr 150,000) associated with cell proliferation.
Chatterjee A; Durban E; Busch H
Cancer Res; 1988 Dec; 48(24 Pt 1):7159-63. PubMed ID: 3191490
[TBL] [Abstract][Full Text] [Related]
8. Effect of differentiation on the expression of a nucleolar antigen with a molecular weight of 145,000 in HL-60 cells.
Freeman JW; Dowell BL; Ochs RL; Ross BE; Busch H
Cancer Res; 1987 Jan; 47(2):586-91. PubMed ID: 3539326
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to human tumor nucleolar antigens: probes for studying biological function and determining clinical significance.
Freeman JW; Busch H
Hum Antibodies Hybridomas; 1991 Jan; 2(1):4-10. PubMed ID: 1873497
[TBL] [Abstract][Full Text] [Related]
10. Optimal loading of scraped HeLa cells with monoclonal antibodies to the proliferation-associated Mr 120,000 nucleolar antigen.
Freeman JW; Hazlewood JE; Auerbach P; Busch H
Cancer Res; 1988 Sep; 48(18):5246-50. PubMed ID: 3044583
[TBL] [Abstract][Full Text] [Related]
11. Novel nucleolar antigens in autoimmune disease.
Busch H; Busch RK; Black A; Chan PK; Chatterjee A; Durban E; Freeman J; Ochs R; Reichlin M; Tan EM
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():70-7. PubMed ID: 2441047
[TBL] [Abstract][Full Text] [Related]
12. Novel cell cycle-related nuclear proteins found in rat and human cells with monoclonal antibodies.
Black A; Freeman JW; Zhou GH; Busch H
Cancer Res; 1987 Jun; 47(12):3266-72. PubMed ID: 3555771
[TBL] [Abstract][Full Text] [Related]
13. Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues.
Chan PK; Frakes R; Tan EM; Brattain MG; Smetana K; Busch H
Cancer Res; 1983 Aug; 43(8):3770-7. PubMed ID: 6134581
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a malignant phenotype-associated cell surface glycoprotein common to various human tumor cells and preferentially expressed on adenocarcinoma of the lung.
Motté P; Takahashi H; Ozturk M; Wilson BE; Wands JR
Cancer Res; 1989 Mar; 49(6):1349-56. PubMed ID: 2924292
[TBL] [Abstract][Full Text] [Related]
16. Intranucleolar localization of human proliferating cell nucleolar antigen p120.
Ochs RL; Reilly MT; Freeman JW; Busch H
Cancer Res; 1988 Nov; 48(22):6523-9. PubMed ID: 3052805
[TBL] [Abstract][Full Text] [Related]
17. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
Takasaki Y; Robinson WA; Tan EM
J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
